Earnings Call Summary | Incyte(INCY.US) Q1 2025 Earnings Conference

moomoo AI13:01 ET · Conference Call

RBC Raises Price Target on Incyte to $67 From $64, Keeps Sector Perform Rating

MT Newswires08:12 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Option Care Health (OPCH), Incyte (INCY) and Verona Pharma (VRNA)

TipRanks08:01 ET · Ratings

Incyte Price Target Raised to $59 From $58 at Wells Fargo

TipRanks07:46 ET

Incyte's Growth Prospects Hindered by Jakafi's Exclusivity Loss and Strategic Limitations

TipRanks07:35 ET

Express News | Incyte : Stifel Cuts Target Price to $75 From $77

Reuters07:07 ET

RBC Capital Remains a Hold on Incyte (INCY)

TipRanks06:54 ET · Ratings

Wells Fargo Remains a Hold on Incyte (INCY)

TipRanks06:23 ET · Ratings

Incyte's Q1 2025 Earnings: Strong Growth and Optimism

TipRanks20:30 ET

BofA Securities Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $89

Moomoo News19:32 ET · Ratings

TD Cowen Maintains Incyte(INCY.US) With Buy Rating, Cuts Target Price to $86

Moomoo News19:32 ET · Ratings

Incyte's Promising Growth Potential and Strategic Positioning Amidst Market Challenges

TipRanks17:06 ET

Incyte | 10-Q: Q1 2025 Earnings Report

SEC16:02 ET · Announcements

Research Alert: CFRA Maintains Buy View On Shares Of Incyte Corporation

MT Newswires15:25 ET

Wells Fargo Hikes Price Target on Incyte to $59 From $58

MT Newswires14:23 ET · Ratings

Jefferies Adjusts Incyte Price Target to $76 From $75

MT Newswires12:36 ET · Ratings

Research Alert: Incy Posts Robust Q1 Results, Beating Expectations

MT NewswiresApr 29 09:35 ET · Ratings

William Blair Maintains Incyte(INCY.US) With Hold Rating

Moomoo NewsApr 29 09:31 ET · Ratings

Express News | Incyte Exec Says Impact of Any Potential Tariffs on Pharmaceuticals to Be "Minimal" - Conf Call

ReutersApr 29 08:47 ET

Express News | Incyte Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results

BenzingaApr 29 08:18 ET